Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers?

作者信息

Pai Amy Barton

机构信息

ANephRx Core Laboratory, Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, Albany, NY, 12208, USA,

出版信息

Clin Pharmacokinet. 2015 Apr;54(4):323-4. doi: 10.1007/s40262-014-0218-2.

DOI:10.1007/s40262-014-0218-2

PMID:25445844

Abstract

摘要

相似文献

Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers?

Clin Pharmacokinet. 2015 Apr;54(4):323-4. doi: 10.1007/s40262-014-0218-2.

Population pharmacokinetic meta-analysis to bridge ferumoxytol plasma pharmacokinetics across populations.

Clin Pharmacokinet. 2015 Apr;54(4):385-95. doi: 10.1007/s40262-014-0203-9.

Safety and effectiveness of ferumoxytol in hemodialysis patients at 3 dialysis chains in the United States over a 12-month period.

Clin Ther. 2014 Jan 1;36(1):70-83. doi: 10.1016/j.clinthera.2013.09.028. Epub 2013 Dec 7.

Ferumoxytol: an intravenous iron, riskier than iron sucrose.

Prescrire Int. 2013 Sep;22(141):206.

[Biochemical plasma parameters in rats during intravenous injection of magnetite nanopowder].

Gig Sanit. 2008 Nov-Dec(6):42-4.

Anemia management in chronic kidney disease: intravenous iron steps forward.

Am J Hematol. 2010 May;85(5):311-2. doi: 10.1002/ajh.21682.

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.

Am J Hematol. 2016 Feb;91(2):E3-5. doi: 10.1002/ajh.24240.

Review of available intravenous iron preparations in hemodialysis.

CANNT J. 2013 Apr-Jun;23(2):51-4; quiz 55-6.

Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.

Nephrol Dial Transplant. 2015 Dec;30(12):2068-75. doi: 10.1093/ndt/gfv305. Epub 2015 Aug 26.

Ferumoxytol for the treatment of iron deficiency.

Expert Rev Hematol. 2011 Aug;4(4):399-406. doi: 10.1586/ehm.11.31.

引用本文的文献

Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a Roadmap.

Clin Pharmacokinet. 2025 Aug 15. doi: 10.1007/s40262-025-01561-w.

Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine.

Pharmacy (Basel). 2022 Jan 21;10(1):17. doi: 10.3390/pharmacy10010017.

The Growing Field of Nanomedicine and Its Relevance to Pharmacy Curricula.

Am J Pharm Educ. 2021 Sep;85(8):8331. doi: 10.5688/ajpe8331. Epub 2021 Feb 24.

本文引用的文献

Population pharmacokinetic meta-analysis to bridge ferumoxytol plasma pharmacokinetics across populations.

Clin Pharmacokinet. 2015 Apr;54(4):385-95. doi: 10.1007/s40262-014-0203-9.

The initial impact of Medicare's new prospective payment system for kidney dialysis.

Am J Kidney Dis. 2013 Oct;62(4):662-9. doi: 10.1053/j.ajkd.2013.03.044. Epub 2013 Jun 13.

Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.

Biometals. 2012 Oct;25(5):961-9. doi: 10.1007/s10534-012-9562-6. Epub 2012 Jun 17.

Nanomedicine(s) under the microscope.

Mol Pharm. 2011 Dec 5;8(6):2101-41. doi: 10.1021/mp200394t. Epub 2011 Oct 26.

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.

Eur J Pharm Biopharm. 2011 Aug;78(3):480-91. doi: 10.1016/j.ejpb.2011.03.016. Epub 2011 Mar 23.

Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects.

Clin Pharmacol Ther. 2010 Aug;88(2):237-42. doi: 10.1038/clpt.2010.80. Epub 2010 Jun 30.

Assessing iron status: beyond serum ferritin and transferrin saturation.

Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4-8. doi: 10.2215/CJN.01490506.

Structure, chemistry, and pharmacokinetics of intravenous iron agents.

J Am Soc Nephrol. 2004 Dec;15 Suppl 2:S93-8. doi: 10.1097/01.ASN.0000143814.49713.C5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验